Prediction of trastuzumab-induced cardiotoxicity using transthoracic echocardiography and cardiac biomarkers in patients with gastric cancer
Not Applicable
- Conditions
- Cancer therapeutics-related cardiac dysfunction
- Registration Number
- JPRN-UMIN000030429
- Lead Sponsor
- Cancer Institute Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
The investigator's consider unsuitable for registration Suitable echocardiographic data can not be obtained for diagnostic imaging Patients can not have clinical examinations due to bad general condition Patients can not visit the hospital periodically
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method